What is Eliquis used for?

Indications and Usage, quoted from the label by E.R. Squibb & Sons, L.L.C. (NDA202155). Cross-references to other label sections are left out.

Reduction of Risk of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation

ELIQUIS is indicated to reduce the risk of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.

Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery

ELIQUIS is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in adult patients who have undergone hip or knee replacement surgery.

Treatment of Deep Vein Thrombosis

ELIQUIS is indicated for the treatment of adults with deep vein thrombosis (DVT).

Treatment of Pulmonary Embolism

ELIQUIS is indicated for the treatment of adults with pulmonary embolism (PE).

Reduction in the Risk of Recurrence of Deep Vein Thrombosis and Pulmonary Embolism

ELIQUIS is indicated to reduce the risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) in adult patients following initial therapy.

Treatment of Venous Thromboembolism and Reduction in the Risk of Recurrent Venous Thromboembolism in Pediatric Patients

ELIQUIS is indicated for the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent VTE in pediatric patients from birth and older after at least 5 days of initial anticoagulant treatment.

Source: DailyMed label, set id e9481622-7cc6-418a-acb6-c5450daae9b0, version 30, effective April 17, 2025. NDC 0003-0893, one of 12 listings for this product.